Atlas Trials

DC1s-CTL Cellular Therapy for Renal Cell Carcinoma

Clinical trial NCT02787915 · UNKNOWN

Trial details

NCT number
NCT02787915
Sponsor
Xuzhou Medical University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2016-09-01
Primary completion
2019-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.